Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹2,163 Cr₹1,911 Cr₹1,656 Cr₹1,245 Cr₹777 Cr

What is the latest Consolidated Net Profit of TORRENT PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of TORRENT PHARMACEUTICALS is ₹2,163 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹2,163 Cr
Mar2025₹1,911 Cr
Mar2024₹1,656 Cr
Mar2023₹1,245 Cr
Mar2022₹777 Cr

How is Consolidated Net Profit of TORRENT PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹2,163 Cr
13.19
Mar2025 ₹1,911 Cr
15.39
Mar2024 ₹1,656 Cr
33.02
Mar2023 ₹1,245 Cr
60.22
Mar2022 ₹777 Cr -

Compare Consolidated Net Profit of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹189,439.2 Cr 1.8% 2.5% 40.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,476.0 Cr -0.1% -2.4% 13.8% Stock Analytics
DIVIS LABORATORIES ₹254,764.0 Cr 2.7% 12.9% 54.4% Stock Analytics
CIPLA ₹111,484.0 Cr 0.6% -3.8% -11.4% Stock Analytics
MANKIND PHARMA ₹101,712.0 Cr 7.3% 3.7% -3.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,005.0 Cr 3.3% 1.3% -7.6% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

1.8%

2.5%

40.9%

SENSEX

0.7%

-3.5%

-9.2%


You may also like the below Video Courses